To identify genes with a potential additive effect to KMT2C mutations in PCa progression, we analysed the MSKCC/DFCI PCa patient cohort and found a significant co-occurrence of alterations in PTEN amongst other genes (Supplementary Fig. 2a). The gene discussed is PTEN; the disease is posterior cortical atrophy.